Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Otsuka
>
Abilify reps leaving?
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 3749610"]Sunovion is putting a ton of resources behind Latuda. They were smart in hiring mostly people who were currently employed with AZ, Janssen, Lily, and BMS/OAPI reps. Those are the 4 most prescribed atypicals so they have put a veteran and experienced salesforce together to launch the drug. I also heard that Andrei Pikalov is with them now which is a major coup for them as well. I think any OAPI rep that left is smart. OAPI has been in a downward spiral for a couple of years now thanks to your current leadership. Sunovion is exactly what OAPI use to be - a smaller, privately owned Japanese pharmaceutical company with a robust pipeline and a management team that doesn't have an identity crisis. Plus they have the financial backing of Sepracor as well. Who wouldn't want to leave OAPI for that environment? Oh yeah, bottom feeders wouldn't want to leave.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 3749610"]Sunovion is putting a ton of resources behind Latuda. They were smart in hiring mostly people who were currently employed with AZ, Janssen, Lily, and BMS/OAPI reps. Those are the 4 most prescribed atypicals so they have put a veteran and experienced salesforce together to launch the drug. I also heard that Andrei Pikalov is with them now which is a major coup for them as well. I think any OAPI rep that left is smart. OAPI has been in a downward spiral for a couple of years now thanks to your current leadership. Sunovion is exactly what OAPI use to be - a smaller, privately owned Japanese pharmaceutical company with a robust pipeline and a management team that doesn't have an identity crisis. Plus they have the financial backing of Sepracor as well. Who wouldn't want to leave OAPI for that environment? Oh yeah, bottom feeders wouldn't want to leave.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Otsuka
>
Abilify reps leaving?
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Otsuka
>
Abilify reps leaving?
>